Hyaluronidase
(Redirected from Vitragan)
Hyaluronidase is an enzyme that catalyzes the degradation of hyaluronic acid (HA), a major component of the extracellular matrix (ECM) in many tissues. By breaking down hyaluronic acid, hyaluronidase lowers the viscosity of hyaluronic acid, making the extracellular matrix more permeable. This action is crucial in processes such as tissue repair, embryonic development, and the spread of pathogenic organisms. Hyaluronidase is used in medicine to enhance the absorption and dispersion of other injected drugs, for subcutaneous fluid administration in hydration, and in ophthalmic surgery to reduce vitreous humor volume, making procedures less invasive.
Function[edit | edit source]
Hyaluronidase enzymes are categorized into several types based on their source and mode of action, including mammalian hyaluronidases and bacterial hyaluronidases. Mammalian hyaluronidases, found in spermatozoa, are involved in fertilization by degrading hyaluronic acid in the corona radiata of the ovum, facilitating sperm penetration. In contrast, bacterial hyaluronidases, which are produced by certain bacteria, act as virulence factors, helping these organisms invade host tissues.
Clinical Use[edit | edit source]
In the clinical setting, hyaluronidase is used to increase the efficacy of drug delivery by promoting the dispersion and absorption of other injected drugs. It is often added to local anesthetic solutions to spread the anesthetic more effectively in the tissue. Hyaluronidase is also utilized in the treatment of hyaluronidosis, a disorder characterized by an abnormal accumulation of hyaluronic acid in the body.
Side Effects and Contraindications[edit | edit source]
While hyaluronidase is generally well tolerated, it can cause side effects in some individuals, including allergic reactions, swelling, and pain at the injection site. It is contraindicated in patients with known hypersensitivity to the enzyme and should be used with caution in individuals with a history of allergy to bee or wasp stings, as these insects' venom contains hyaluronidase.
Research and Future Directions[edit | edit source]
Research into hyaluronidase has expanded its potential therapeutic applications, including its use in cancer therapy to break down the extracellular matrix of tumors, potentially improving the efficacy of anticancer drugs. Additionally, its role in improving the clinical outcomes of other treatments, such as dermal fillers and antibody therapies, is being explored.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD